Therapeutically active compounds and their methods of use Grant US-11844758-B2 United States of America 19 Dec 2023
Pyruvate kinase activators for use in therapy Grant US-11793806-B2 United States of America 24 Oct 2023
Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-11723905-B2 United States of America 15 Aug 2023
Therapeutically active compounds and their methods of use Grant US-11667673-B2 United States of America 06 Jun 2023
Pharmaceutical compositions of therapeutically active compounds Grant US-11504361-B2 United States of America 22 Nov 2022
Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation Grant US-11497743-B2 United States of America 15 Nov 2022
Combination therapy for treating malignancies Grant US-11419859-B2 United States of America 23 Aug 2022
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Grant US-11311527-B2 United States of America 26 Apr 2022
Methods of using pyruvate kinase activators Grant US-11234976-B2 United States of America 01 Feb 2022
Therapeutically active compounds and their methods of use Grant US-11021515-B2 United States of America 01 Jun 2021
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation Grant US-11013734-B2 United States of America 25 May 2021
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) Grant US-11013733-B2 United States of America 25 May 2021
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10959994-B2 United States of America 30 Mar 2021
Therapeutically active compounds and their methods of use Grant US-10946023-B2 United States of America 16 Mar 2021
Combination therapy for treating malignancies Grant US-10905692-B2 United States of America 02 Feb 2021
Pharmaceutical compositions of therapeutically active compounds Grant US-10799490-B2 United States of America 13 Oct 2020
Therapeutically active compounds and their methods of use Grant US-10717764-B2 United States of America 21 Jul 2020
Methods for diagnosing IDH-mutant cell proliferation disorders Grant US-10711314-B2 United States of America 14 Jul 2020
Combination therapy for treating malignancies Grant US-10695352-B2 United States of America 30 Jun 2020
Therapeutically active compounds and their methods of use Grant US-10689414-B2 United States of America 23 Jun 2020
Combination therapy for treating malignancies Grant US-10653710-B2 United States of America 19 May 2020
Therapeutically active compositions and their methods of use Grant US-10640534-B2 United States of America 05 May 2020
Pyruvate kinase activators for use in therapy Grant US-10632114-B2 United States of America 28 Apr 2020
Methods and compositions for cell-proliferation-related disorders Grant US-10610125-B2 United States of America 07 Apr 2020
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10532047-B2 United States of America 14 Jan 2020
METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS Application EP-3561077-A1 European Patent Office 30 Oct 2019
Pharmaceutical compositions of therapeutically active compounds Grant US-10449184-B2 United States of America 22 Oct 2019
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of… Grant US-10376510-B2 United States of America 13 Aug 2019
COCRYSTALS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATMENT INVOLVING SAME Application WO-2019090059-A1 World Intellectual Property Organisation (WIPO) 09 May 2019
Therapeutic compounds and compositions Application US-10202339-B2 United States of America 12 Feb 2019
Therapeutically active compounds and their methods of use Grant US-10172864-B2 United States of America 08 Jan 2019
METHODS OF TREATMENT OF MYELOPROLIFERATIVE NEOPLASM Application WO-2018204787-A1 World Intellectual Property Organisation (WIPO) 08 Nov 2018
Therapeutically active compounds and their methods of use Grant US-10028961-B2 United States of America 24 Jul 2018
Therapeutically active compounds and their methods of use Grant US-10017495-B2 United States of America 10 Jul 2018
Pyruvate kinase activators for use in therapy Grant US-9980961-B2 United States of America 29 May 2018
Method for treating cell proliferation related disorders Application US-9982309-B2 United States of America 29 May 2018
Pharmaceutical compositions of therapeutically active compounds Grant US-9968595-B2 United States of America 15 May 2018
METHODS OF TREATMENT OF MYELODYSPLASTIC SYNDROME Application WO-2018026894-A1 World Intellectual Property Organisation (WIPO) 08 Feb 2018
Therapeutically active compositions and their methods of use Grant US-9856279-B2 United States of America 02 Jan 2018
Therapeutically active compositions and their methods of use Grant US-9850277-B2 United States of America 26 Dec 2017
IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMOURS Application WO-2017146795-A1 World Intellectual Property Organisation (WIPO) 31 Aug 2017
IDH2 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGANCIES AND SOLID TUMOURS Application WO-2017146794-A1 World Intellectual Property Organisation (WIPO) 31 Aug 2017
Therapeutically active compounds and their methods of use Grant US-9732062-B2 United States of America 15 Aug 2017
METHODS OF TREATMENT OF MALIGNACIES Application WO-2017096309-A1 World Intellectual Property Organisation (WIPO) 08 Jun 2017
METHODS OF TREATMENT OF MALIGNANCIES Application WO-2017096150-A1 World Intellectual Property Organisation (WIPO) 08 Jun 2017
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1… Grant US-9662327-B2 United States of America 30 May 2017
COMBINATION THERAPY FOR TREATING MALIGNANCIES Application WO-2017066599-A1 World Intellectual Property Organisation (WIPO) 20 Apr 2017
Therapeutically active compounds and their methods of use Grant US-9579324-B2 United States of America 28 Feb 2017
Therapeutically active compositions and their methods of use Application US-9474779-B2 United States of America 25 Oct 2016
METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS Application EP-3064595-A1 European Patent Office 07 Sep 2016
Methods and compositions for cell-proliferation-related disorders Application US-9434979-B2 United States of America 06 Sep 2016
Method for diagnosing cell proliferation disorders having a neoactive mutation at residue… Application US-8883438-B2 United States of America 11 Nov 2014
METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS Application US-20140187435-A1 United States of America 03 Jul 2014
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE Application WO-2013102431-A1 World Intellectual Property Organisation (WIPO) 11 Jul 2013
METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS Application WO-2011050210-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2011